Dusa Pharmaceuticals (DUSA) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Dusa Pharmaceuticals, Inc. (NYSE: DUSA) | Delayed: 56.62 -0.03 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.65 | 52 Week High | $8.01 | |||
| Open | $56.50 | 52 Week Low | $4.10 | |||
| Day High | $56.73 | P/E | 471.83 | |||
| Day Low | $56.50 | EPS | $0.12 | |||
| Volume | 5,660 | |||||
